| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $332.3M | +96.1% |
| SG&A Expense | $60.7M | +52.5% |
| Operating Income | -$468.0M | -101.5% |
| Interest Expense | $0 | -100.0% |
| Net Income | -$402.3M | -80.0% |
| EPS (Basic) | -$4.14 | -20.3% |
| EPS (Diluted) | -$4.14 | -20.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $397.5M | -52.4% |
| Short-term Investments | $682.8M | +605.9% |
| Current Assets | $1.10B | +16.3% |
| Total Assets | $1.41B | +39.9% |
| Current Liabilities | $145.3M | +258.6% |
| Total Liabilities | $167.4M | +218.6% |
| Stockholders' Equity | $1.24B | +30.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$296.8M | -74.0% |
| Capital Expenditures | $16.1M | +174.7% |
| Investing Cash Flow | -$773.3M | -1136.8% |
| Financing Cash Flow | $639.8M | -25.7% |
| Free Cash Flow | -$312.9M | -77.3% |